Share-based Payment Arrangement, Expense of Caris Life Sciences, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Caris Life Sciences, Inc. annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
Caris Life Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $13,655,000, a 189% increase year-over-year.
Caris Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $70,006,000, a 276% increase from 2024.
Caris Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $18,643,000, a 22% increase from 2023.
Source SEC data: View on sec.gov

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$70,006,000	+$51,363,000	+276%	01 Jan 2025	31 Dec 2025	10-K	03 Mar 2026	2025	FY
2024	$18,643,000	+$3,403,000	+22%	01 Jan 2024	31 Dec 2024	10-K	03 Mar 2026	2025	FY
2023	$15,240,000			01 Jan 2023	31 Dec 2023	10-K	03 Mar 2026	2025	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$13,655,000	+$8,932,000	+189%	01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$28,293,000	+$23,808,000	+531%	01 Apr 2025	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q3 2024	$4,723,000			01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024	$4,485,000			01 Apr 2024	30 Jun 2024	10-Q	12 Aug 2025	2025	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.